RFA
SGMO

Reyes Financial Architecture’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Reyes Financial Architecture’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-500
Closed -$510 – 352
2024
Q4 		$510 Buy
+500
New +$914 ﹤0.01% 277

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Reyes Financial Architecture's SGMO Position: Q1 2025 in Review

Reyes Financial Architecture sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 500 shares — an estimated $510 sold.

Reyes Financial Architecture first reported a position in SGMO in Q4 2024 and held it in 1 quarter. The position peaked at $510 in Q4 2024. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Reyes Financial Architecture reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Reyes Financial Architecture sold 500 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $510.
  • Reyes Financial Architecture first reported a position in SANGAMO THERAPEUTICS INC in Q4 2024 and held it in 1 quarter.
  • Reyes Financial Architecture's SANGAMO THERAPEUTICS INC position peaked at $510 in Q4 2024.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on Reyes Financial Architecture's 13F filing for Q1 2025, filed 1 May 2025.